- Conditions
- Osteoporosis
- Interventions
- Raloxifene, Zoledronic acid, Placebo oral pills, Placebo intravenous (i.v.) infusion
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 45 Years to 80 Years · Female only
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Buena Park, California • Washington D.C., District of Columbia + 12 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Osteoporosis, Postmenopausal, Osteoporosis
- Interventions
- Romosozumab, Teriparatide
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Osteoporosis, Humoral Hypercalcemia of Malignancy, Hyperparathyroidism
- Interventions
- PTHrP (1-36)
- Drug
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 24 Years to 35 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Osteoporosis
- Interventions
- Teriparatide, Denosumab, Demeclocycline, Tetracycline, Calcium Supplement, Vitamin D
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 55 Years to 89 Years · Female only
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 4
- States / cities
- Lakewood, Colorado • Gainesville, Georgia • Detroit, Michigan + 1 more
- Conditions
- Postmenopausal Osteoporosis, Osteoporosis
- Interventions
- synthetic hPTH 1-34
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 46 Years to 85 Years · Female only
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Osteoporosis
- Interventions
- Placebo, Green Tea Polyphenols (GTP), Placebo+Tai Chi (TC), GTP+TC
- Drug
- Lead sponsor
- Texas Tech University Health Sciences Center
- Other
- Eligibility
- Female only
- Enrollment
- 171 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Lubbock, Texas
- Conditions
- Osteoporosis Postmenopausal
- Interventions
- Risedronate (HMR4003)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 50 Years and older · Female only
- Enrollment
- 1,231 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Osteoporosis, Postmenopausal, Osteoporosis
- Interventions
- denosumab, alendronate, raloxifene
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 51 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2023
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Postmenopausal, Osteopenia, Rheumatoid Arthritis, Osteoporosis
- Interventions
- Etanercept, Denosumab
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 45 Years to 80 Years · Female only
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 2
- States / cities
- Duncansville, Pennsylvania • Dallas, Texas
- Conditions
- Osteoporosis
- Interventions
- PTH, Alendronate
- Drug
- Lead sponsor
- Dennis Black
- Other
- Eligibility
- 55 Years to 85 Years · Female only
- Enrollment
- 238 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1999 – 2007
- U.S. locations
- 4
- States / cities
- Bangor, Maine • Minneapolis, Minnesota • New York, New York + 1 more
- Conditions
- Osteoporosis, Osteoporosis, Postmenopausal
- Interventions
- Parathyroid Hormone-related Protein, Placebo
- Drug
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 50 Years to 75 Years · Female only
- Enrollment
- 61 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2008
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Osteoporosis
- Interventions
- PTH/Calcium, PTH/placebo, placebo
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 374 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 17
- States / cities
- Rancho Cucamonga, California • Lake Worth, Florida • Coeur d'Alene, Idaho + 14 more
- Conditions
- Perimenopausal Bone Loss
- Interventions
- Prunes, Calcium supplement, Vitamin D Supplement
- Dietary Supplement
- Lead sponsor
- Penn State University
- Other
- Eligibility
- 44 Years to 55 Years · Female only
- Enrollment
- 124 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- University Park, Pennsylvania
- Conditions
- Breast Cancer, Osteoporosis
- Interventions
- biologic sample preservation procedure, dual x-ray absorptometry
- Other · Procedure
- Lead sponsor
- NCIC Clinical Trials Group
- Network
- Eligibility
- 35 Years and older · Female only
- Enrollment
- 238 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2013
- U.S. locations
- 13
- States / cities
- Torrance, California • Washington D.C., District of Columbia • Scarborough, Maine + 9 more
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Risedronate, Raloxifene, Placebo
- Drug · Other
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- Up to 65 Years · Female only
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- teriparatide, raloxifene, placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 45 Years to 85 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 13
- States / cities
- Anaheim, California • Oakland, California • Altamonte Springs, Florida + 10 more
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Not listed
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 50 Years and older · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Postmenopausal Bone Loss, Breast Cancer
- Interventions
- Not listed
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Breast Neoplasm, Osteoporosis, Postmenopausal
- Interventions
- Resistance Exercise, Flexibility Training
- Behavioral
- Lead sponsor
- OHSU Knight Cancer Institute
- Other
- Eligibility
- Female only
- Enrollment
- 71 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Osteoporosis
- Interventions
- SB-751689
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 35 Years to 65 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures
- Interventions
- denosumab, Placebo, Calcium and Vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- Susan L. Greenspan
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 201 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2023
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Alendronate, Ibandronate
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- Female only
- Enrollment
- 341 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 54
- States / cities
- Huntsville, Alabama • Phoenix, Arizona • Tempe, Arizona + 47 more
- Conditions
- Postmenopausal Women With Osteoporosis
- Interventions
- Romosozumab, Alendronate, Placebo to Romosozumab, Placebo to Alendronate
- Biological · Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 55 Years to 90 Years · Female only
- Enrollment
- 4,093 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Peoria, Arizona • Phoenix, Arizona + 29 more
- Conditions
- Osteopenia, Osteoporosis
- Interventions
- Alendronate, Estrogen/progestin therapy
- Drug
- Lead sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- NIH
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 240 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1999 – 2004
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska